Cargando…
Inhibitory Monoclonal Antibodies against Mouse Proteases Raised in Gene-Deficient Mice Block Proteolytic Functions in vivo
Identification of targets for cancer therapy requires the understanding of the in vivo roles of proteins, which can be derived from studies using gene-targeted mice. An alternative strategy is the administration of inhibitory monoclonal antibodies (mAbs), causing acute disruption of the target prote...
Autores principales: | Lund, Ida K., Rasch, Morten G., Ingvarsen, Signe, Pass, Jesper, Madsen, Daniel H., Engelholm, Lars H., Behrendt, Niels, Høyer-Hansen, Gunilla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384954/ https://www.ncbi.nlm.nih.gov/pubmed/22754528 http://dx.doi.org/10.3389/fphar.2012.00122 |
Ejemplares similares
-
Differential Actions of the Endocytic Collagen Receptor uPARAP/Endo180 and the Collagenase MMP-2 in Bone Homeostasis
por: Madsen, Daniel H., et al.
Publicado: (2013) -
The collagen receptor uPARAP/Endo180 as a novel target for antibody-drug conjugate mediated treatment of mesenchymal and leukemic cancers
por: Nielsen, Christoffer Fagernæs, et al.
Publicado: (2017) -
Tumor cell MT1-MMP is dispensable for osteosarcoma tumor growth, bone degradation and lung metastasis
por: Ingvarsen, Signe Z., et al.
Publicado: (2020) -
The collagen receptor uPARAP/Endo180 in tissue degradation and cancer (Review)
por: MELANDER, MARIA C., et al.
Publicado: (2015) -
Neutralisation of uPA with a Monoclonal Antibody Reduces Plasmin Formation and Delays Skin Wound Healing in tPA-Deficient Mice
por: Jögi, Annika, et al.
Publicado: (2010)